多发性骨髓瘤骨病外科治疗循证医学指南

2018-04-30 中国医师协会骨科医师分会 骨肿瘤工作委员会 中华骨与关节外科杂志.2018,11(4):252-260.

大部分多发性骨髓瘤患者在病程中会出现骨髓瘤骨病,严重影响患者的生活质量和生存率。规范的化疗、靶向治疗和双膦酸盐是治疗多发性骨髓瘤骨病的基础和最重要的部分。外科手术在多发性骨髓瘤骨病急性并发症(病理性骨折、脊柱不稳和脊髓压迫症等)的治疗中发挥着重要作用。中国医师协会骨科医师分会骨肿瘤专业委员会依据循证医学方法制定了《多发性骨髓瘤骨病外科治疗循证医学指南》,分别就外科治疗时机、手术指征、不同部位的手术

中文标题:

多发性骨髓瘤骨病外科治疗循证医学指南

发布日期:

2018-04-30

简要介绍:

大部分多发性骨髓瘤患者在病程中会出现骨髓瘤骨病,严重影响患者的生活质量和生存率。规范的化疗、靶向治疗和双膦酸盐是治疗多发性骨髓瘤骨病的基础和最重要的部分。外科手术在多发性骨髓瘤骨病急性并发症(病理性骨折、脊柱不稳和脊髓压迫症等)的治疗中发挥着重要作用。中国医师协会骨科医师分会骨肿瘤专业委员会依据循证医学方法制定了《多发性骨髓瘤骨病外科治疗循证医学指南》,分别就外科治疗时机、手术指征、不同部位的手术方式及综合治疗等临床问题进行总结,依据文献证据等级给出相应的推荐等级。专业委员会希望本指南能够为骨肿瘤医师的临床诊疗提供最佳的、有效的意见参考,从而使患者达到最佳的治疗效果。而本指南仅为学术性指导意见,具体实施时必须依据患者的个体医疗情况而定。 

拓展指南:多发性骨髓瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=多发性骨髓瘤骨病外科治疗循证医学指南)] GetToolGuiderByIdResponse(projectId=1, id=7fbbf1c00159ea01, title=多发性骨髓瘤骨病外科治疗循证医学指南, enTitle=, guiderFrom=中华骨与关节外科杂志.2018,11(4):252-260., authorId=null, author=, summary=大部分多发性骨髓瘤患者在病程中会出现骨髓瘤骨病,严重影响患者的生活质量和生存率。规范的化疗、靶向治疗和双膦酸盐是治疗多发性骨髓瘤骨病的基础和最重要的部分。外科手术在多发性骨髓瘤骨病急性并发症(病理性骨折、脊柱不稳和脊髓压迫症等)的治疗中发挥着重要作用。中国医师协会骨科医师分会骨肿瘤专业委员会依据循证医学方法制定了《多发性骨髓瘤骨病外科治疗循证医学指南》,分别就外科治疗时机、手术指征、不同部位的手术, cover=, journalId=null, articlesId=null, associationId=1661, associationName=中国医师协会骨科医师分会 骨肿瘤工作委员会, associationIntro=, copyright=0, guiderPublishedTime=Mon Apr 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>大部分多发性骨髓瘤患者在病程中会出现骨髓瘤骨病,严重影响患者的生活质量和生存率。规范的化疗、靶向治疗和双膦酸盐是治疗多发性骨髓瘤骨病的基础和最重要的部分。外科手术在多发性骨髓瘤骨病急性并发症(病理性骨折、脊柱不稳和脊髓压迫症等)的治疗中发挥着重要作用。中国医师协会骨科医师分会骨肿瘤专业委员会依据循证医学方法制定了《多发性骨髓瘤骨病外科治疗循证医学指南》,分别就外科治疗时机、手术指征、不同部位的手术方式及综合治疗等临床问题进行总结,依据文献证据等级给出相应的推荐等级。专业委员会希望本指南能够为骨肿瘤医师的临床诊疗提供最佳的、有效的意见参考,从而使患者达到最佳的治疗效果。而本指南仅为学术性指导意见,具体实施时必须依据患者的个体医疗情况而定。 </div> <div><br> </div>拓展指南:<strong>与<font color="red">多发性骨髓瘤</font>相关指南:</strong><br><ul><li><a title="NCCN临床实践指南:多发性骨髓瘤(2018.V4)" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=64d2e1c00156324a">NCCN临床实践指南:多发性骨髓瘤(2018.V4)</a></li> <li><a title="2017 EMN共识:多发性骨髓瘤新药不良事件的预防和管理" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=31f191c00153a10d">2017 EMN共识:多发性骨髓瘤新药不良事件的预防和管理</a></li> <li><a title="2017年欧洲肿瘤内科学会多发性骨髓瘤的指南更新解读" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=9b91f1c00152ae45">2017年欧洲肿瘤内科学会多发性骨髓瘤的指南更新解读</a></li> <li><a title="《中国多发性骨髓瘤诊治指南(2017年修订)》复发/难治骨髓瘤治疗部分的解读" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=dc1db1c00152a016">《中国多发性骨髓瘤诊治指南(2017年修订)》复发/难治骨髓瘤治疗部分的解读</a></li> <li><a title="《中国多发性骨髓瘤诊治指南(2017年修订)》初始治疗部分的解读" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=5c5d21c0015231cb">《中国多发性骨髓瘤诊治指南(2017年修订)》初始治疗部分的解读</a></li> 更多信息请点击:<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E5%A4%9A%E5%8F%91%E6%80%A7%E9%AA%A8%E9%AB%93%E7%98%A4">有关多发性骨髓瘤更多指南</a></ul>, tagList=[TagDto(tagId=37825, tagName=多发性骨髓瘤骨病), TagDto(tagId=2738, tagName=外科治疗)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6826, appHits=230, showAppHits=0, pcHits=5552, showPcHits=1468, likes=185, shares=6, comments=3, approvalStatus=1, publishedTime=Tue May 29 22:17:08 CST 2018, publishedTimeString=2018-04-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue May 29 22:17:08 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:37:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=多发性骨髓瘤骨病外科治疗循证医学指南)])
多发性骨髓瘤骨病外科治疗循证医学指南
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=319808, encodeId=dc64319808e1, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed May 30 01:29:36 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319763, encodeId=a5ed319e63a2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Tue May 29 22:44:59 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319758, encodeId=4de3319e58dd, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue May 29 22:34:55 CST 2018, time=2018-05-29, status=1, ipAttribution=)]
    2018-05-30 329523732

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=319808, encodeId=dc64319808e1, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed May 30 01:29:36 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319763, encodeId=a5ed319e63a2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Tue May 29 22:44:59 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319758, encodeId=4de3319e58dd, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue May 29 22:34:55 CST 2018, time=2018-05-29, status=1, ipAttribution=)]
    2018-05-29 happsf

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=319808, encodeId=dc64319808e1, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed May 30 01:29:36 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319763, encodeId=a5ed319e63a2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Tue May 29 22:44:59 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319758, encodeId=4de3319e58dd, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue May 29 22:34:55 CST 2018, time=2018-05-29, status=1, ipAttribution=)]
    2018-05-29 wqkm

    ^_^^_^^_^

    0